(Clockwise from top left): Justin Ergler, director of alternative fee intelligence and analytics at GlaxoSmithKline; Lizzy McLellan, senior editor, Business of Law at ALM; Daniel Lewis, head of practical guidance at LexisNexis; and Heidi Gardner, distinguished fellow at Harvard Law School, speak during a Legal Week panel.
Justin Ergler, director of alternative fee intelligence and analytics at GlaxoSmithKline in Raleigh, North Carolina, said GlaxoSmithKline has moved away from the billable hour, and is now in flat-fee arrangements with its outside counsel. However, that change took the better part of a decade to achieve.
“Change, even with great ideas, is oftentimes resisted until the very last second, until you have to change,” Ergler said.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
